相关实验视频
Updated: Jan 29, 2026

18:48
Murine Renal Transplantation Procedure
Published on: July 10, 2009
30.6K
干净间歇性导管对儿科脏移植患者坚持治疗的影响
Sarah Ashley1, Arun Chandnani2, Carter Sevick3
1University of Colorado School of Medicine, Aurora, Colorado, USA.
Pediatric transplantation
|January 28, 2026
概括
需要干净间歇性导管 (CIC) 的儿科移植候选人表现出较低的治疗坚持. 老年也增加了不坚持的风险,强调了对这些脆弱患者进行早期干预的需要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植手术 移植手术
- 儿科医学 儿科医学
背景情况:
- 治疗的坚持对于成功的移植结果至关重要.
- 干净间歇性导管 (CIC) 对儿科移植候选人的坚持的影响尚不清楚.
研究的目的:
- 研究儿科移植候选人的医学诊断因素与治疗坚持之间的关联.
- 评估CIC和患者年龄在使用儿科移植评分仪器 (P-TRI) 预测坚持的作用.
主要方法:
- 对180名儿科移植候选人进行了回顾性图表审查.
- 数据包括人口统计,诊断,导管状态和年龄.
- 使用P-TRI子尺度评估依从性,并使用累积后勤回归分析差异.
主要成果:
- 在移植前使用CIC的患者的坚持度得分明显较低 (OR 0.46,p=0.021).
- 年龄较大与坚持能力降低相关 (斯皮尔曼相关性-0.25,p<0.001).
结论:
- 移植前CIC的使用是降低患者坚持治疗的风险因素.
- 年长的儿科患者也面临更高的不坚持的风险.
- 识别这些风险因素可以进行有针对性的干预,以优化移植候选人的坚持.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism
213
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
272
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
272
Cardiac Catheterization II: Right Heart Catheterization
942
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
942
Pharmacodynamics in Geriatric Patients: Effects of Age
202
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
202

